Humana Shares Plunge Following Earnings Forecast Slash
Published on 11/10/2025 at 12:01 | Redaktion boerse-global.de
US health insurer Humana witnessed a dramatic sell-off in its stock after presenting mixed quarterly results and significantly revising its full-year earnings guidance downward. Although adjusted earnings surpassed market expectations, investors reacted sharply to the reduced GAAP profit outlook, driving the share price down more than 12% within days.
A significant factor behind the negative investor sentiment stems from a legal ruling on October 14, 2025. Humana lost a court dispute concerning its Medicare Advantage Star Ratings for 2025. This legal defeat is projected to have substantial financial repercussions in 2026, including:
- A reduction in the proportion of Medicare members enrolled in highly-rated plans, falling to 20% from a previous 25%.
- An estimated Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
